These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15184443)

  • 1. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.
    Dobbs T; Kennedy S; Pau CP; McDougal JS; Parekh BS
    J Clin Microbiol; 2004 Jun; 42(6):2623-8. PubMed ID: 15184443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.
    Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.
    Parekh BS; Kennedy MS; Dobbs T; Pau CP; Byers R; Green T; Hu DJ; Vanichseni S; Young NL; Choopanya K; Mastro TD; McDougal JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):295-307. PubMed ID: 11860677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of transmission time in HIV infections and an epidemiological prospective follow-up study for 1 year in the Marmara Region of Turkey.
    Celik DG; Yuksel P; Aslan M; Saribas S; Baltali ND; Abdelkareem A; Ziver T; Nazlican O; Gencer S; Celikkol E; Bahar H; Kocazeybek B
    Transfus Apher Sci; 2012 Aug; 47(1):3-7. PubMed ID: 22483628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device.
    Granade TC; Nguyen S; Kuehl DS; Parekh BS
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):61-7. PubMed ID: 23281586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.
    Dobbs T; Liu X; Anderson R; Nkengasong J; Parekh BS
    J Clin Microbiol; 2011 Oct; 49(10):3470-3. PubMed ID: 21832016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.
    Soroka SD; Granade TC; Candal D; Parekh BS
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):918-21. PubMed ID: 16085908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.
    Jiang Y; Wang M; Ni M; Duan S; Wang Y; Feng J; Xiao Y; Dong Y; Wang D; Han M; Xiang L; Ma L; Zhou Q
    AIDS; 2007 Dec; 21 Suppl 8():S47-51. PubMed ID: 18172391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay.
    Nesheim S; Parekh B; Sullivan K; Bulterys M; Dobbs T; Lindsay M; Cashat-Cruz M; Byers B; Lee F
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):537-44. PubMed ID: 15989458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.
    Hayashida T; Gatanaga H; Tanuma J; Oka S
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):495-8. PubMed ID: 18327979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 incidence estimates among young Thai men using IgG-capture BED-enzyme immunoassay (BED-CEIA) during 2005-2006.
    Kana K; Tabprasit S; Chuenchitra T; Sirisopana N; Rangsin R
    J Med Assoc Thai; 2009 Feb; 92 Suppl 1():S112-6. PubMed ID: 21299183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
    McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
    Wendel SK; Mullis CE; Eshleman SH; Blankson JN; Moore RD; Keruly JC; Brookmeyer R; Quinn TC; Laeyendecker O
    PLoS One; 2013; 8(2):e55525. PubMed ID: 23437058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two serological tests for the identification of recent HIV infection: Vironostika HIV-1 Microelisa and BED capture enzyme immunoassay.
    Romero A; Martró E; González V; Matas L;
    Enferm Infecc Microbiol Clin; 2011; 29(7):553-5. PubMed ID: 21501904
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
    Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
    Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays.
    Hladik W; Olara D; Mermin J; Moore D; Were W; Alexander L; Downing R
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):95-9. PubMed ID: 21314476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
    Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N;
    AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.